DiaMedica reports Q3 2026 results, trial milestones in FGR and stroke programsNov 12Quarterly updateDiaMedica Therapeutics Inc
DiaMedica posts Phase 2 DM199 kidney disease results, years after trial completionNov 10Trial updateDiaMedica Therapeutics Increcombinant human tissue kallikrein
DiaMedica reports Q2 2026 results, adds FGR enrollment and PE dose plansAug 10Quarterly updateDiaMedica Therapeutics Inc